Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 519

1.

Targeting the COX1/2-Driven thromboxane A2 pathway suppresses Barrett's esophagus and esophageal adenocarcinoma development.

Zhang T, Wang Q, Ma WY, Wang K, Chang X, Johnson ML, Bai R, Bode AM, Foster NR, Falk GW, Limburg PJ, Iyer PG, Dong Z.

EBioMedicine. 2019 Nov 6. pii: S2352-3964(19)30709-1. doi: 10.1016/j.ebiom.2019.10.038. [Epub ahead of print]

2.

Is repairing giant hiatal hernia in patients over 80 worth the risk?

Khoma O, Mugino M, Falk GL.

Surgeon. 2019 Oct 18. pii: S1479-666X(19)30118-0. doi: 10.1016/j.surge.2019.09.004. [Epub ahead of print]

PMID:
31630975
3.

Risk awareness for proton pump inhibition: Necessitates review of recommendations in anti-reflux disease.

Falk GL.

Surgeon. 2019 Oct 11. pii: S1479-666X(19)30115-5. doi: 10.1016/j.surge.2019.09.001. [Epub ahead of print] No abstract available.

PMID:
31610985
4.

Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis.

Hirano I, Dellon ES, Hamilton JD, Collins MH, Peterson K, Chehade M, Schoepfer AM, Safroneeva E, Rothenberg ME, Falk GW, Assouline-Dayan Y, Zhao Q, Chen Z, Swanson BN, Pirozzi G, Mannent L, Graham NMH, Akinlade B, Stahl N, Yancopoulos GD, Radin A.

Gastroenterology. 2019 Oct 5. pii: S0016-5085(19)41415-7. doi: 10.1053/j.gastro.2019.09.042. [Epub ahead of print]

5.

Persistent Basal Cell Hyperplasia Is Associated With Clinical and Endoscopic Findings in Patients With Histologically Inactive Eosinophilic Esophagitis.

Whelan KA, Godwin BC, Wilkins B, Elci OU, Benitez A, DeMarshall M, Sharma M, Gross J, Klein-Szanto AJ, Liacouras CA, Dellon ES, Spergel JM, Falk GW, Muir AB, Nakagawa H.

Clin Gastroenterol Hepatol. 2019 Sep 6. pii: S1542-3565(19)30977-2. doi: 10.1016/j.cgh.2019.08.055. [Epub ahead of print]

PMID:
31499251
6.

Correction: Flow based single cell analysis of the immune landscape distinguishes Barrett's esophagus from adjacent normal tissue.

Sen M, Hahn F, Black TA, DeMarshall M, Porter W, Snowden E, Yee SS, Tong F, Ferguson M, Fleshman EN, Nakagawa H, Falk GW, Ginsberg GG, Kochman ML, Blaesius R, Rustgi AK, Carpenter EL.

Oncotarget. 2019 Aug 20;10(49):5119. doi: 10.18632/oncotarget.27161. eCollection 2019 Aug 20.

7.

Low Yield of Cross-Sectional Imaging in Patients With Esophagogastric Junction Outflow Obstruction.

Beveridge CA, Falk GW, Ahuja NK, Yang YX, Metz DC, Lynch KL.

Clin Gastroenterol Hepatol. 2019 Jul 27. pii: S1542-3565(19)30788-8. doi: 10.1016/j.cgh.2019.07.044. [Epub ahead of print]

PMID:
31362120
8.

Exocrine pancreatic insufficiency in distal pancreatectomy: incidence and risk factors.

Hallac A, Aleassa EM, Rogers M, Falk GA, Morris-Stiff G.

HPB (Oxford). 2019 Jul 18. pii: S1365-182X(19)30604-5. doi: 10.1016/j.hpb.2019.06.017. [Epub ahead of print]

PMID:
31327560
9.

Flow based single cell analysis of the immune landscape distinguishes Barrett's esophagus from adjacent normal tissue.

Sen M, Hahn F, Black TA, DeMarshall M, Porter W, Snowden E, Yee SS, Tong F, Ferguson M, Fleshman EN, Nakagawa H, Falk GW, Ginsberg GG, Kochman ML, Blaesius R, Rustgi AK, Carpenter EL.

Oncotarget. 2019 Jun 4;10(38):3592-3604. doi: 10.18632/oncotarget.26911. eCollection 2019 Jun 4. Erratum in: Oncotarget. 2019 Aug 20;10(49):5119.

10.

Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter Consortium.

Pesek RD, Reed CC, Muir AB, Fulkerson PC, Menard-Katcher C, Falk GW, Kuhl J, Martin EK, Magier AZ, Ahmed F, Demarshall M, Gupta A, Gross J, Ashorobi T, Carpenter CL, Krischer JP, Gonsalves N, Spergel JM, Gupta SK, Furuta GT, Rothenberg ME, Dellon ES; Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).

Am J Gastroenterol. 2019 Jun;114(6):984-994. doi: 10.14309/ajg.0000000000000228.

PMID:
31008735
11.

High-resolution genomic alterations in Barrett's metaplasia of patients who progress to esophageal dysplasia and adenocarcinoma.

Sepulveda JL, Komissarova EV, Kongkarnka S, Friedman RA, Davison JM, Levy B, Bryk D, Jobanputra V, Del Portillo A, Falk GW, Sonett JR, Lightdale CJ, Abrams JA, Wang TC, Sepulveda AR.

Int J Cancer. 2019 Nov 15;145(10):2754-2766. doi: 10.1002/ijc.32351. Epub 2019 May 2.

PMID:
31001805
12.

Overestimation of the diagnosis of eosinophilic colitis with reliance on billing codes.

Muir AB, Jensen ET, Wechsler JB, Menard-Katcher P, Falk GW, Aceves SS, Furuta GT, Dellon ES, Rothenberg ME, Spergel JM.

J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2434-2436. doi: 10.1016/j.jaip.2019.03.020. Epub 2019 Mar 25. No abstract available.

PMID:
30922989
13.

Fibrostenotic eosinophilic esophagitis might reflect epithelial lysyl oxidase induction by fibroblast-derived TNF-α.

Kasagi Y, Dods K, Wang JX, Chandramouleeswaran PM, Benitez AJ, Gambanga F, Kluger J, Ashorobi T, Gross J, Tobias JW, Klein-Szanto AJ, Spergel JM, Cianferoni A, Falk GW, Whelan KA, Nakagawa H, Muir AB.

J Allergy Clin Immunol. 2019 Jul;144(1):171-182. doi: 10.1016/j.jaci.2018.10.067. Epub 2018 Dec 20.

PMID:
30578874
14.

Variation in Endoscopic Activity Assessment and Endoscopy Score Validation in Adults With Eosinophilic Esophagitis.

Schoepfer AM, Hirano I, Coslovsky M, Roumet MC, Zwahlen M, Kuehni CE, Hafner D, Alexander JA, Dellon ES, Gonsalves N, Leung J, Bussmann C, Collins MH, Newbury RO, Smyrk TC, Woosley JT, Yang GY, Romero Y, Katzka DA, Furuta GT, Gupta SK, Aceves SS, Chehade M, Spergel JM, Falk GW, Meltzer BA, Comer GM, Straumann A, Safroneeva E; International EEsAI Study Group.

Clin Gastroenterol Hepatol. 2019 Jul;17(8):1477-1488.e10. doi: 10.1016/j.cgh.2018.11.032. Epub 2018 Nov 23.

PMID:
30476587
15.

Consortium of Eosinophilic Gastrointestinal Disease Researchers: Advancing the Field of Eosinophilic GI Disorders Through Collaboration.

Gupta SK, Falk GW, Aceves SS, Chehade M, Collins MH, Dellon ES, Gonsalves N, Hirano I, Mukkuda VA, Peterson KA, Spergel J, Yang GY, Furuta GT, Rothenberg ME; Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).

Gastroenterology. 2019 Mar;156(4):838-842. doi: 10.1053/j.gastro.2018.10.057. Epub 2018 Nov 17. No abstract available.

PMID:
30452923
16.

2017 David Sun Lecture: Screening and Surveillance of Barrett's Esophagus: Where Are We Now and What Does the Future Hold?

Falk GW.

Am J Gastroenterol. 2019 Jan;114(1):64-70. doi: 10.1038/s41395-018-0374-3.

PMID:
30361622
17.

Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium.

Desai M, Lieberman DA, Kennedy KF, Hamade N, Thota P, Parasa S, Gorrepati VS, Bansal A, Gupta N, Gaddam S, Young PE, Mathur S, Moawad FJ, Cash BD, Sampliner R, Vargo JJ, Falk GW, Sharma P.

Gastrointest Endosc. 2019 Feb;89(2):257-263.e3. doi: 10.1016/j.gie.2018.09.041. Epub 2018 Oct 17.

PMID:
30342028
18.

Benchmarking of a Simple Scintigraphic Test for Gastro-oesophageal Reflux Disease That Assesses Oesophageal Disease and Its Pulmonary Complications

Burton L, Falk GL, Parsons S, Cusi M, Van Der Wall H.

Mol Imaging Radionucl Ther. 2018 Oct 9;27(3):113-120. doi: 10.4274/mirt.10438.

19.

Gastro-oesophageal fistula in an achalasia patient following myotomy as an unusual cause of heartburn.

Falk GL, Little SC.

Ann R Coll Surg Engl. 2019 Feb;101(2):e35-e37. doi: 10.1308/rcsann.2018.0179. Epub 2018 Oct 5.

PMID:
30286658
20.

Resistance Training Alone or Combined With N-3 PUFA-Rich Diet in Older Women: Effects on Muscle Fiber Hypertrophy.

Strandberg E, Ponsot E, Piehl-Aulin K, Falk G, Kadi F.

J Gerontol A Biol Sci Med Sci. 2019 Mar 14;74(4):489-494. doi: 10.1093/gerona/gly130.

PMID:
30052800
21.

Lower Annual Rate of Progression of Short-Segment vs Long-Segment Barrett's Esophagus to Esophageal Adenocarcinoma.

Hamade N, Vennelaganti S, Parasa S, Vennalaganti P, Gaddam S, Spaander MCW, van Olphen SH, Thota PN, Kennedy KF, Bruno MJ, Vargo JJ, Mathur S, Cash BD, Sampliner R, Gupta N, Falk GW, Bansal A, Young PE, Lieberman DA, Sharma P.

Clin Gastroenterol Hepatol. 2019 Apr;17(5):864-868. doi: 10.1016/j.cgh.2018.07.008. Epub 2018 Aug 8.

PMID:
30012433
22.

Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference.

Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N, Spechler SJ, Attwood SE, Straumann A, Aceves SS, Alexander JA, Atkins D, Arva NC, Blanchard C, Bonis PA, Book WM, Capocelli KE, Chehade M, Cheng E, Collins MH, Davis CM, Dias JA, Di Lorenzo C, Dohil R, Dupont C, Falk GW, Ferreira CT, Fox A, Gonsalves NP, Gupta SK, Katzka DA, Kinoshita Y, Menard-Katcher C, Kodroff E, Metz DC, Miehlke S, Muir AB, Mukkada VA, Murch S, Nurko S, Ohtsuka Y, Orel R, Papadopoulou A, Peterson KA, Philpott H, Putnam PE, Richter JE, Rosen R, Rothenberg ME, Schoepfer A, Scott MM, Shah N, Sheikh J, Souza RF, Strobel MJ, Talley NJ, Vaezi MF, Vandenplas Y, Vieira MC, Walker MM, Wechsler JB, Wershil BK, Wen T, Yang GY, Hirano I, Bredenoord AJ.

Gastroenterology. 2018 Oct;155(4):1022-1033.e10. doi: 10.1053/j.gastro.2018.07.009. Epub 2018 Sep 6. Review.

23.

Pneumothorax: Laparoscopic Intraoperative Management During Fundoplication Facilitates Management of Cardiopulmonary Instability and Surgical Exposure.

Falk GL, D'Netto TJ, Phillips S, Little SC.

J Laparoendosc Adv Surg Tech A. 2018 Nov;28(11):1371-1373. doi: 10.1089/lap.2018.0050. Epub 2018 Jun 29.

PMID:
29958063
24.

Alignment of parent- and child-reported outcomes and histology in eosinophilic esophagitis across multiple CEGIR sites.

Aceves SS, King E, Collins MH, Yang GY, Capocelli KE, Abonia JP, Atkins D, Bonis PA, Carpenter CL, Dellon ES, Eby MD, Falk GW, Gonsalves N, Gupta SK, Hirano I, Kocher K, Krischer JP, Leung J, Lipscomb J, Menard-Katcher P, Mukkada VA, Pan Z, Spergel JM, Sun Q, Wershil BK, Rothenberg ME, Furuta GT; Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).

J Allergy Clin Immunol. 2018 Jul;142(1):130-138.e1. doi: 10.1016/j.jaci.2018.05.014. Epub 2018 May 29.

25.

Gastro-Oesophageal Reflux and Aspiration: Does Laparoscopic Fundoplication Significantly Decrease Pulmonary Aspiration?

Khoma O, Falk SE, Burton L, Van der Wall H, Falk GL.

Lung. 2018 Aug;196(4):491-496. doi: 10.1007/s00408-018-0128-4. Epub 2018 May 26.

PMID:
29804143
26.

Left atrial compression and right ventricular outflow tract diameter on echocardiography are independently associated with exercise capacity in patients with large hiatal hernia.

Naoum C, Kritharides L, Falk GL, Martin D, Yiannikas J.

Echocardiography. 2018 May;35(5):592-602. doi: 10.1111/echo.13835.

PMID:
29790224
27.

Successful conservative management of an intramural gastric abscess: a case report.

Salim J, Menon T, Drummond R, Page PL, Falk G.

ANZ J Surg. 2019 Sep;89(9):E383-E384. doi: 10.1111/ans.14554. Epub 2018 May 14. No abstract available.

PMID:
29756672
28.

Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study.

Shoda T, Wen T, Aceves SS, Abonia JP, Atkins D, Bonis PA, Caldwell JM, Capocelli KE, Carpenter CL, Collins MH, Dellon ES, Eby MD, Gonsalves N, Gupta SK, Falk GW, Hirano I, Menard-Katcher P, Kuhl JT, Krischer JP, Leung J, Mukkada VA, Spergel JM, Trimarchi MP, Yang GY, Zimmermann N, Furuta GT, Rothenberg ME; Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).

Lancet Gastroenterol Hepatol. 2018 Jul;3(7):477-488. doi: 10.1016/S2468-1253(18)30096-7. Epub 2018 May 3.

29.

Clinical Guidelines Update on the Diagnosis and Management of Barrett's Esophagus.

Clermont M, Falk GW.

Dig Dis Sci. 2018 Aug;63(8):2122-2128. doi: 10.1007/s10620-018-5070-z. Review.

PMID:
29671159
30.

Natural history of eosinophilic esophagitis: a systematic review of epidemiology and disease course.

Shaheen NJ, Mukkada V, Eichinger CS, Schofield H, Todorova L, Falk GW.

Dis Esophagus. 2018 Aug 1;31(8). doi: 10.1093/dote/doy015.

31.

The Esophageal Organoid System Reveals Functional Interplay Between Notch and Cytokines in Reactive Epithelial Changes.

Kasagi Y, Chandramouleeswaran PM, Whelan KA, Tanaka K, Giroux V, Sharma M, Wang J, Benitez AJ, DeMarshall M, Tobias JW, Hamilton KE, Falk GW, Spergel JM, Klein-Szanto AJ, Rustgi AK, Muir AB, Nakagawa H.

Cell Mol Gastroenterol Hepatol. 2018 Jan 3;5(3):333-352. doi: 10.1016/j.jcmgh.2017.12.013. eCollection 2018 Mar.

32.

Novel Modified Seldinger Technique for Gastrojejunal Feeding Tube Placement.

Moslim MA, Falk GA, Seifarth FG.

JSLS. 2018 Jan-Mar;22(1). pii: e2017.00091. doi: 10.4293/JSLS.2017.00091.

33.

Association of sporadic and familial Barrett's esophagus with breast cancer.

Chan MQ, Blum AE, Chandar AK, Emmons AMLK, Shindo Y, Brock W, Falk GW, Canto MI, Wang JS, Iyer PG, Shaheen NJ, Grady WM, Abrams JA, Thota PN, Guda KK, Chak A.

Dis Esophagus. 2018 Apr 1;31(4). doi: 10.1093/dote/doy007.

34.

Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer.

Thota PN, Arora Z, Dumot JA, Falk G, Benjamin T, Goldblum J, Jang S, Lopez R, Vargo JJ.

Dig Dis Sci. 2018 May;63(5):1311-1319. doi: 10.1007/s10620-018-5009-4. Epub 2018 Mar 9.

PMID:
29524114
35.

Achalasia Patients Are at Nutritional Risk Regardless of Presenting Weight Category.

Newberry C, Vajravelu RK, Pickett-Blakely O, Falk G, Yang YX, Lynch KL.

Dig Dis Sci. 2018 May;63(5):1243-1249. doi: 10.1007/s10620-018-4985-8. Epub 2018 Feb 22.

PMID:
29468378
36.

Creating a multi-center rare disease consortium - the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).

Cheng K, Gupta SK, Kantor S, Kuhl JT, Aceves SS, Bonis PA, Capocelli KE, Carpenter C, Chehade M, Collins MH, Dellon ES, Falk GW, Gopal-Srivastava R, Gonsalves N, Hirano I, King EC, Leung J, Krischer JP, Mukkada VA, Schoepfer A, Spergel JM, Straumann A, Yang GY, Furuta GT, Rothenberg ME.

Transl Sci Rare Dis. 2017 Dec 18;2(3-4):141-155. doi: 10.3233/TRD-170016.

37.

Lack of proton pump inhibitor trial prior to commencing therapy for eosinophilic esophagitis is common in the community.

Whitson MJ, Lynch KL, Yang YX, Metz DC, Falk GW.

Dis Esophagus. 2018 May 1;31(5). doi: 10.1093/dote/dox143.

PMID:
29293904
38.

Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.

Parasa S, Vennalaganti S, Gaddam S, Vennalaganti P, Young P, Gupta N, Thota P, Cash B, Mathur S, Sampliner R, Moawad F, Lieberman D, Bansal A, Kennedy KF, Vargo J, Falk G, Spaander M, Bruno M, Sharma P.

Gastroenterology. 2018 Apr;154(5):1282-1289.e2. doi: 10.1053/j.gastro.2017.12.009. Epub 2017 Dec 19.

PMID:
29273452
39.

Does hiatal repair affect gastroesophageal reflux symptoms in patients undergoing laparoscopic sleeve gastrectomy?

Page PL, Martin D, Taylor C, Wang J, Wadhawan H, Falk G, Gibson SC.

Surg Endosc. 2018 May;32(5):2373-2380. doi: 10.1007/s00464-017-5935-9. Epub 2017 Dec 12.

PMID:
29234942
40.

A Novel Technique of Paravertebral Thoracic and Preperitoneal Analgesia Enhances Early Recovery After Oesophagectomy.

Phillips S, Dedic-Hagan J, Baxter DF, Van der Wall H, Falk GL.

World J Surg. 2018 Jun;42(6):1787-1791. doi: 10.1007/s00268-017-4369-9.

PMID:
29164294
41.

Genomic regions associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma in African Americans: The cross BETRNet admixture study.

Sun X, Chandar AK, Canto MI, Thota PN, Brock M, Shaheen NJ, Beer DG, Wang JS, Falk GW, Iyer PG, Abrams JA, Venkat-Ramani M, Veigl M, Miron A, Willis J, Patil DT, Nalbantoglu I, Guda K, Markowitz SD, Zhu X, Elston R, Chak A.

PLoS One. 2017 Oct 26;12(10):e0184962. doi: 10.1371/journal.pone.0184962. eCollection 2017.

42.

Long-term outcomes for cryotherapy in Barrett's esophagus with high-grade dysplasia: just cracking the ice.

Das KK, Falk GW.

Gastrointest Endosc. 2017 Oct;86(4):633-635. doi: 10.1016/j.gie.2017.03.1540. No abstract available.

PMID:
28917343
43.

Increased detection of Barrett's esophagus-associated neoplasia using wide-area trans-epithelial sampling: a multicenter, prospective, randomized trial.

Vennalaganti PR, Kaul V, Wang KK, Falk GW, Shaheen NJ, Infantolino A, Johnson DA, Eisen G, Gerson LB, Smith MS, Iyer PG, Lightdale CJ, Schnoll-Sussman F, Gupta N, Gross SA, Abrams J, Haber GB, Chuttani R, Pleskow DK, Kothari S, Goldblum JR, Zhang Y, Sharma P.

Gastrointest Endosc. 2018 Feb;87(2):348-355. doi: 10.1016/j.gie.2017.07.039. Epub 2017 Jul 27.

PMID:
28757316
44.

Valsalva maneuver exacerbates left atrial compression in patients with large hiatal hernia.

Naoum C, Kritharides L, Gnanenthiran SR, Martin D, Falk GL, Yiannikas J.

Echocardiography. 2017 Sep;34(9):1305-1314. doi: 10.1111/echo.13628. Epub 2017 Jul 18.

PMID:
28722185
45.

Health-Related Quality of Life and Costs Associated With Eosinophilic Esophagitis: A Systematic Review.

Mukkada V, Falk GW, Eichinger CS, King D, Todorova L, Shaheen NJ.

Clin Gastroenterol Hepatol. 2018 Apr;16(4):495-503.e8. doi: 10.1016/j.cgh.2017.06.036. Epub 2017 Jun 24.

46.

Modeling Esophagitis Using Human Three-Dimensional Organotypic Culture System.

Laczkó D, Wang F, Johnson FB, Jhala N, Rosztóczy A, Ginsberg GG, Falk GW, Rustgi AK, Lynch JP.

Am J Pathol. 2017 Aug;187(8):1787-1799. doi: 10.1016/j.ajpath.2017.04.013. Epub 2017 Jun 13.

47.

Acute massive gastric dilatation causing ischaemic necrosis and perforation of the stomach.

Moslim MA, Mittal J, Falk GA, Ustin JS, Morris-Stiff G.

BMJ Case Rep. 2017 Jun 15;2017. pii: bcr-2016-218513. doi: 10.1136/bcr-2016-218513.

48.

Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium.

Wani S, Muthusamy VR, Shaheen NJ, Yadlapati R, Wilson R, Abrams JA, Bergman J, Chak A, Chang K, Das A, Dumot J, Edmundowicz SA, Eisen G, Falk GW, Fennerty MB, Gerson L, Ginsberg GG, Grande D, Hall M, Harnke B, Inadomi J, Jankowski J, Lightdale CJ, Makker J, Odze RD, Pech O, Sampliner RE, Spechler S, Triadafilopoulos G, Wallace MB, Wang K, Waxman I, Komanduri S.

Gastrointest Endosc. 2017 Jul;86(1):1-17.e3. doi: 10.1016/j.gie.2017.03.010. Epub 2017 May 30. Review. No abstract available.

PMID:
28576294
49.

Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett's Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium.

Wani S, Muthusamy VR, Shaheen NJ, Yadlapati R, Wilson R, Abrams JA, Bergman J, Chak A, Chang K, Das A, Dumot J, Edmundowicz SA, Eisen G, Falk GW, Fennerty MB, Gerson L, Ginsberg GG, Grande D, Hall M, Harnke B, Inadomi J, Jankowski J, Lightdale CJ, Makker J, Odze RD, Pech O, Sampliner RE, Spechler S, Triadafilopoulos G, Wallace MB, Wang K, Waxman I, Komanduri S.

Am J Gastroenterol. 2017 Jul;112(7):1032-1048. doi: 10.1038/ajg.2017.166. Epub 2017 Jun 1. Review. No abstract available.

PMID:
28570552
50.

Current Management of Low-Grade Dysplasia in Barrett Esophagus.

Falk GW.

Gastroenterol Hepatol (N Y). 2017 Apr;13(4):221-225.

Supplemental Content

Support Center